Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer.
Vetter M, Landin J, Szczerba BM, Castro-Giner F, Gkountela S, Donato C, Krol I, Scherrer R, Balmelli C, Malinovska A, Zippelius A, Kurzeder C, Heinzelmann-Schwarz V, Weber WP, Rochlitz C, Aceto N.
Vetter M, et al. Among authors: malinovska a.
Breast Cancer Res. 2018 Nov 20;20(1):141. doi: 10.1186/s13058-018-1067-y.
Breast Cancer Res. 2018.
PMID: 30458879
Free PMC article.